Copolov DL - Search Results

1

Differential role of serotonergic projections arising from the dorsal and median raphe nuclei in locomotor hyperactivity and prepulse inhibition.

Kusljic S, Copolov DL, van den Buuse M. Kusljic S, et al. Among authors: copolov dl. Neuropsychopharmacology. 2003 Dec;28(12):2138-47. doi: 10.1038/sj.npp.1300277. Neuropsychopharmacology. 2003. PMID: 12888784

2

Interaction of glutathione depletion and psychotropic drug treatment in prepulse inhibition in rats and mice.

Dean O, Bush AI, Berk M, Copolov DL, van den Buuse M. Dean O, et al. Among authors: copolov dl. Pharmacol Biochem Behav. 2010 Dec;97(2):293-300. doi: 10.1016/j.pbb.2010.08.013. Epub 2010 Sep 9. Pharmacol Biochem Behav. 2010. PMID: 20816888

3

Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice.

Dean O, Bush AI, Berk M, Copolov DL, van den Buuse M. Dean O, et al. Among authors: copolov dl. Behav Brain Res. 2009 Mar 2;198(1):258-62. doi: 10.1016/j.bbr.2008.11.017. Epub 2008 Nov 18. Behav Brain Res. 2009. PMID: 19061918

4

N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: relevance to schizophrenia and bipolar disorder.

Dean OM, van den Buuse M, Berk M, Copolov DL, Mavros C, Bush AI. Dean OM, et al. Among authors: copolov dl. Neurosci Lett. 2011 Jul 25;499(3):149-53. doi: 10.1016/j.neulet.2011.05.027. Epub 2011 May 20. Neurosci Lett. 2011. PMID: 21621586

5

An animal model of chronic placental insufficiency: relevance to neurodevelopmental disorders including schizophrenia.

Rehn AE, Van Den Buuse M, Copolov D, Briscoe T, Lambert G, Rees S. Rehn AE, et al. Neuroscience. 2004;129(2):381-91. doi: 10.1016/j.neuroscience.2004.07.047. Neuroscience. 2004. PMID: 15501595

6

Differential effects of acute serotonin and dopamine depletion on prepulse inhibition and p50 suppression measures of sensorimotor and sensory gating in humans.

Mann C, Croft RJ, Scholes KE, Dunne A, O'Neill BV, Leung S, Copolov D, Phan KL, Nathan PJ. Mann C, et al. Neuropsychopharmacology. 2008 Jun;33(7):1653-66. doi: 10.1038/sj.npp.1301556. Epub 2007 Sep 26. Neuropsychopharmacology. 2008. PMID: 17895917 Clinical Trial.

7

A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice.

Dean OM, van den Buuse M, Bush AI, Copolov DL, Ng F, Dodd S, Berk M. Dean OM, et al. Among authors: copolov dl. Curr Med Chem. 2009;16(23):2965-76. doi: 10.2174/092986709788803060. Curr Med Chem. 2009. PMID: 19689277 Review.

8

[3H]paroxetine binding is altered in the hippocampus but not the frontal cortex or caudate nucleus from subjects with schizophrenia.

Dean B, Opeskin K, Pavey G, Naylor L, Hill C, Keks N, Copolov DL. Dean B, et al. Among authors: copolov dl. J Neurochem. 1995 Mar;64(3):1197-202. doi: 10.1046/j.1471-4159.1995.64031197.x. J Neurochem. 1995. PMID: 7861151

9

No change in the density of the serotonin1A receptor, the serotonin4 receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophrenia.

Dean B, Tomaskovic-Crook E, Opeskin K, Keks N, Copolov D. Dean B, et al. Neurochem Int. 1999 Feb;34(2):109-15. doi: 10.1016/s0197-0186(98)00074-6. Neurochem Int. 1999. PMID: 10213068

10

Studies on serotonergic markers in the human hippocampus: changes in subjects with bipolar disorder.

Dean B, Scarr E, Pavey G, Copolov D. Dean B, et al. J Affect Disord. 2003 Jun;75(1):65-9. doi: 10.1016/s0165-0327(02)00021-6. J Affect Disord. 2003. PMID: 12781352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters